Resmed (RMD) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Resmed (RMD) over the last 17 years, with Q4 2025 value amounting to $2.68.
- Resmed's EPS (Weighted Average and Diluted) rose 1452.99% to $2.68 in Q4 2025 from the same period last year, while for Dec 2025 it was $10.11, marking a year-over-year increase of 1936.25%. This contributed to the annual value of $9.51 for FY2025, which is 3738.06% up from last year.
- According to the latest figures from Q4 2025, Resmed's EPS (Weighted Average and Diluted) is $2.68, which was up 1452.99% from $2.37 recorded in Q3 2025.
- In the past 5 years, Resmed's EPS (Weighted Average and Diluted) ranged from a high of $2.68 in Q4 2025 and a low of -$0.54 during Q1 2021
- In the last 5 years, Resmed's EPS (Weighted Average and Diluted) had a median value of $1.54 in 2023 and averaged $1.68.
- As far as peak fluctuations go, Resmed's EPS (Weighted Average and Diluted) tumbled by 14821.43% in 2021, and later soared by 32592.59% in 2022.
- Over the past 5 years, Resmed's EPS (Weighted Average and Diluted) (Quarter) stood at $1.37 in 2021, then rose by 11.68% to $1.53 in 2022, then decreased by 7.19% to $1.42 in 2023, then surged by 64.79% to $2.34 in 2024, then increased by 14.53% to $2.68 in 2025.
- Its EPS (Weighted Average and Diluted) stands at $2.68 for Q4 2025, versus $2.37 for Q3 2025 and $2.58 for Q2 2025.